Bosentan波生坦水合物,157212-55-0

MCE 的所有产品仅用作科学研究或药证申报，我们不为任何个人用途提供产品和服务。

Bosentan hydrate

CAS No. : 157212-55-0

MCE 国际站：Bosentan hydrate

产品活性：Bosentan hydrate 是一种竞争性的 endothelin-1 (ET) 拮抗剂，在人SMC中，作用于 ET_A 和 ET_B 受体，K_i 分别为 4.7 nM 和 95 nM。

研究领域：GPCR/G Protein

作用靶点：Endothelin Receptor

In Vitro: Bosentan (BOS) competitively and specifically antagonizes binding of ¹²⁵I-labelled ET-1 to ET_A receptors on human smooth muscle cells (SMC) and ET_B receptors on human placenta cells. The in vitro binding affinity of Bosentan to ET_A receptors on human SMC is 4.7 nM and to ET_B receptors on human SMC or placenta cells is 41 or 95 nM. Bosentan has 67-fold greater selectivity for ET_A than ET_B receptors (mean IC₅₀=7.1 vs 474.8 nM) in an in vitro ¹²⁵I-labeling assay.

In Vivo: In hypertensive rats, Macitentan 30 mg/kg further decreases mean arterial blood pressure (MAP) by 19 mm Hg when given on top of Bosentan hydrate 100 mg/kg. Conversely, Bosentan hydrate given on top of Macitentan fails to induce an additional MAP decrease. In pulmonary hypertensive rats, Macitentan 30 mg/kg further decreases mean pulmonary artery pressure (MPAP) by 4 mm Hg on top of Bosentan hydrate, whereas a maximal effective dose of Bosentan hydrate given on top of Macitentan does not cause any additional MPAP decrease.

相关产品：Drug Repurposing Compound Library Plus  |  FDA-Approved Drug Library Plus  |  FDA-Approved Drug Library Mini  |  Bioactive Compound Library Plus  |  GPCR/G Protein Compound Library  |  FDA-Approved Drug Library  |  Anti-Cancer Compound Library  |  Drug Repurposing Compound Library  |  Anti-Cardiovascular Disease Compound Library  |  Endocrinology Compound Library  |  Orally Active Compound Library  |  Neurotransmitter Receptor Compound Library  |  FDA Approved & Pharmacopeial Drug Library  |  Drug-Induced Liver Injury (DILI) Compound Library  |  Anti-Pancreatic Cancer Compound Library  |  Angiogenesis-Related Compound Library  |  Rare Diseases Drug Library  |  Children’s Drug Library  |  EMA-Approved Drug Library  |  FDA-Approved Anticancer Drug Library  |  Human Metabolite Library  |  Anti-Pulmonary Fibrosis Compound Library  |  Coagulation and Anti-coagulation Compound Library  |  Pain-Related Compound Library  |  Off-patent Drug Library  |  Antihypertensive Compound Library  |  Membrane Protein-targeted Compound Library  |  Membrane Receptor-targeted Compound Library  |  Endothelin 1 (swine, human)  |  Bosentan  |  Macitentan  |  Ambrisentan  |  Atrasentan hydrochloride  |  BQ-123  |  BQ-788  |  Carperitide acetate  |  Atrial Natriuretic Peptide (ANP) (1-28), rat  |  Sulfisoxazole  |  Endothelin-3, human, mouse, rabbit, rat TFA  |  Sparsentan  |  Zibotentan  |  A-192621  |  Sitaxsentan sodium  |  IRL-1620 TFA  |  Clazosentan  |  Nebentan potassium  |  Avosentan  |  Aprocitentan  |  Tezosentan  |  Darusentan  |  IRL 2500

热门产品线：重组蛋白  |  化合物库  |  天然产物  |  荧光染料  |  PROTAC  |  同位素标记物

Trending products：Recombinant Proteins  |  Bioactive Screening Libraries  |  Natural Products  |  Dye Reagents  |  PROTAC  |  Isotope-Labeled Compounds